Screener
Biogen BIIB Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| (In millions) | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | $(25.3) | $(32.3) | $(63.2) | $(56.2) |
| Interest expense | 82.3 | 72.6 | 149.9 | 132.6 |
| (Gains) losses on investments, net | (41.6) | (5.3) | (63.9) | 30.3 |
| Litigation related expense | (0.4) | 5.2 | 4.3 | 8.2 |
| Foreign exchange (gains) losses, net | 6.5 | 10.4 | 13.0 | 6.6 |
| Other, net | (3.0) | (1.9) | (1.9) | (4.4) |
| Total other (income) expense, net | $18.5 | $48.7 | $38.2 | $117.1 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's other income, net (note 6)?
- Biogen (BIIB) reported other income, net (note 6) of $3M in Q2 2026.
- How has Biogen's other income, net (note 6) changed year-over-year?
- Biogen's other income, net (note 6) increased by 190.9% year-over-year, from -$3.3M to $3M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about Biogen's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude